Spencer Trask & Co. Investor

Spencer Trask & Co. operates as a venture capital firm. The Company specializing in emerging growth, startups, and early stage investments. Spencer Trask & Co operates in the United States.Several Spencer Trask-backed technologies and companies have been acquired recently, including OpenTable ($2.6 billion), Prolor (stock swap worth $1.2 billion), ImThera Medical ($225 million), El Super (more than $1 billion in revenues) and Prospect Medical ($363 million). Spencer Trask & Co., has been instrumental in the formative stage of companies that pioneered many technological and scientific advances, including: genomics with Myriad Genetics, healthcare reform with Health Dialog,development with Intellectual Ventures,
Technology: N/A
Industry: Regenerative Medicine
Headquarters: New York, New York, United States
Founded Date: 1982
Employees Number: undisclosed
Funding Status: undisclosed
Investor Type: Private Equity Firm
Investment Stage: Early Stage Venture, Private Equity, Seed
Number Of Exits: 5

Visit Website
Register and Claim Ownership